US Patent 7122324 Vitro methods for determining in vivo thrombotic events
Patent 7122324 was granted and assigned to the scripps research institute on October, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+202 characters)
Article
Patent abstract
Diagnostic systems, methods, polypeptides and antibodies for detecting the presence of C-terminal hGPIIb fragment of the platelet receptor GPIIb-IIIa in a body fluid sample are disclosed.
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07122324 Vitro methods for determining in vivo thrombotic events US Patent 7122324 Vitro methods for determining in vivo thrombotic events
Infobox
Patent Number
0712232400
Patent Number
712232400
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071223240
Date of Patent
October 17, 2006
0Patent Application Number
109347740
Date Filed
September 3, 2004
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
071223240
Date of Patent
October 17, 2006
0Patent Application Number
109347740
Date Filed
September 3, 2004
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 18 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07122324 Vitro methods for determining in vivo thrombotic events
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07122324
Date of patent
October 17, 2006
Patent application number
10934774
Date Filed
September 3, 2004
Patent primary examiner
Find more entities like US Patent 7122324 Vitro methods for determining in vivo thrombotic events
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
